BUTTARI, FABIO
 Distribuzione geografica
Continente #
AS - Asia 1.253
NA - Nord America 1.128
EU - Europa 696
SA - Sud America 293
AF - Africa 29
Totale 3.399
Nazione #
US - Stati Uniti d'America 1.014
SG - Singapore 423
CN - Cina 315
DE - Germania 280
BR - Brasile 220
HK - Hong Kong 186
IT - Italia 133
FR - Francia 93
VN - Vietnam 93
DO - Repubblica Dominicana 53
KR - Corea 53
BD - Bangladesh 39
RU - Federazione Russa 38
GB - Regno Unito 37
CA - Canada 35
AR - Argentina 31
FI - Finlandia 28
IN - India 28
ID - Indonesia 17
TR - Turchia 17
MX - Messico 16
EE - Estonia 15
IQ - Iraq 15
PL - Polonia 15
NL - Olanda 11
PK - Pakistan 11
CO - Colombia 10
EC - Ecuador 10
BE - Belgio 8
ES - Italia 8
JP - Giappone 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
EG - Egitto 7
SA - Arabia Saudita 7
UA - Ucraina 7
NP - Nepal 6
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
SE - Svezia 5
CL - Cile 4
IL - Israele 4
MY - Malesia 4
PH - Filippine 4
RS - Serbia 4
VE - Venezuela 4
BH - Bahrain 3
CR - Costa Rica 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
OM - Oman 2
RO - Romania 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 3.399
Città #
San Jose 301
Singapore 240
Hong Kong 185
Falkenstein 157
Ashburn 146
Beijing 95
Frankfurt am Main 91
West Jordan 62
Rome 58
Chicago 53
Seoul 51
Sosua, Cabarete 51
Dallas 47
Lauterbourg 45
Boardman 38
Ho Chi Minh City 36
Buffalo 28
Los Angeles 28
São Paulo 22
Munich 20
New York 20
Toronto 16
Orem 15
Santa Clara 15
Turku 15
Helsinki 13
Moscow 13
London 10
Montreal 9
Rio de Janeiro 9
Belo Horizonte 8
Brooklyn 8
Brussels 8
Dhaka 8
Hanoi 8
Mexico City 8
Tashkent 8
Warsaw 8
Charlotte 7
Chennai 7
San Francisco 7
Tokyo 7
Curitiba 6
Hillsboro 6
Mumbai 6
Ottawa 6
Suzhou 6
The Dalles 6
Bexley 5
Council Bluffs 5
Hải Dương 5
Istanbul 5
Milan 5
Naples 5
Wroclaw 5
Belgrade 4
Bogotá 4
Bologna 4
Brasília 4
Cairo 4
Erbil 4
Guayaquil 4
Ninh Bình 4
Porto Alegre 4
Quito 4
Sant'Elpidio a Mare 4
Stockholm 4
Tianjin 4
Vinh 4
Amsterdam 3
Ankara 3
Asunción 3
Atlanta 3
Baghdad 3
Bauru 3
Cape Town 3
Cincinnati 3
Da Nang 3
Denver 3
Eagleville 3
Ettlingen 3
Galbiate 3
Haiphong 3
Ituzaingó 3
Jeddah 3
Karachi 3
Lima 3
Manchester 3
Mar del Plata 3
Montevideo 3
Nairobi 3
Pasadena 3
Piscataway 3
Quảng Ngãi 3
San Justo 3
Seattle 3
Secaucus 3
Shanghai 3
Almirante Tamandaré 2
Americana 2
Totale 2.199
Nome #
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 125
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 110
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 105
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 103
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 101
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 95
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 94
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 92
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 90
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 82
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 82
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 78
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 75
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 75
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 74
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 71
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 70
Osteopontin Is Associated with Multiple Sclerosis Relapses 69
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 68
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 66
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 66
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 64
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 64
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 63
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 63
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 62
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 62
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 62
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 61
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 61
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 61
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 60
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 60
Obesity worsens central inflammation and disability in multiple sclerosis 60
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 59
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 59
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 59
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 56
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 56
Synaptic plasticity shapes brain connectivity: Implications for network topology 56
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 56
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 55
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 55
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 51
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 49
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 49
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 48
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 47
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 44
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 43
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 41
Totale 3.477
Categoria #
all - tutte 17.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024198 0 0 0 0 0 0 45 0 0 125 15 13
2024/2025886 35 45 7 49 81 57 187 186 52 35 138 14
2025/20262.393 184 196 263 308 118 72 376 249 250 149 115 113
Totale 3.477